News
2424 posts · page 74 of 101
APIs Revolutionize Access to Real-Time Global Tariff Data
Global trade experts increasingly rely on APIs for accurate, up-to-date tariff information, enhancing decision-making and compliance.
India's Pharma Exports Overtake Imports, Reaching Rs 41,500 Cr in FY25
India's pharmaceutical sector sees a boost as exports of active ingredients surpass imports, marking a significant trade milestone.
Molbio Diagnostics Eyes ₹200 Crore Through IPO Amidst Global Expansion
Molbio Diagnostics plans to raise ₹200 crore via IPO for expansion, while reducing promoter stake to 43%.
Medical Device Firms Oppose Bill Equating Devices with Drugs
India's medical device sector challenges a draft bill treating devices as pharmaceuticals, citing regulatory and innovation concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO Amidst Global Expansion
Molbio Diagnostics is launching an IPO to raise ₹940 crore, aiming to bolster capital expenditures and reduce promoter stake.
Indian Medical Device Industry Rejects Equating Devices with Pharma in New Bill
Industry leaders argue the Draft Bill's pharma-style regulations threaten innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fund Expansion
Molbio Diagnostics seeks to raise ₹940 crore through IPO for expansion and stake reduction, targeting long-term growth.
Medical Device Industry Challenges India's Draft Regulation Bill
India's medical device sector opposes the draft bill treating devices like drugs, citing potential harm to innovation and investment.
Molbio Diagnostics IPO: A High-Risk Bet for Potential Long-Term Gains
Molbio Diagnostics seeks to raise ₹940 crore via IPO to fund expansion and reduce promoter stake. Investors weigh high-risk, high-reward potential.
Industry Criticizes Draft Bill for Treating Medical Devices as Drugs
The medical device sector opposes the 2026 draft bill, arguing it aligns devices with pharmaceuticals, risking innovation and growth.
Molbio Diagnostics' IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics seeks to raise ₹940 crore via IPO to fund expansion and promoter stake reduction.
Trump Alters Childhood Vaccine Schedule Amid Criticism
President Trump signs an executive order changing the childhood vaccine schedule, sparking controversy.
Medical Device Firms Oppose Draft Bill Treating Devices as Drugs
India's medical device sector challenges draft bill equating devices with pharmaceuticals, fearing impacts on innovation and investment.
Bangladesh to Launch Nationwide Health Screening Initiative
Bangladesh is set to introduce a door-to-door health screening program, aiming to improve access to medical care across the country.
Beyond Checkups: Comprehensive Health for Executives Gains Urgency
Executives are shifting towards comprehensive health strategies that extend beyond routine checkups to safeguard their well-being.
Health Challenges Loom Over U.S. C-Suite Executives
U.S. executives face increasing health issues, impacting business productivity.
Ivory Launches Initiative to Screen for Mental Health Risks
Ivory introduces a proactive brain screening program to detect mental health issues before they manifest.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, aiming to bolster its global diagnostics footprint.
AI Breakthrough Offers New Fertility Hope for Men with Low Sperm Counts
AI technology is revolutionizing fertility treatment by identifying viable sperm in men with low sperm counts, enhancing chances for biological parenthood.
Medical Device Sector Challenges India's New Regulatory Bill
Industry opposes treating devices as drugs in the draft Drugs, Medical Devices, and Cosmetics Bill 2026.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, aiming to expand and reduce promoter stake.
Medical Device Industry Pushes Back Against India's Draft Bill 2026
India's medical device sector challenges the 2026 Draft Bill, warning it stifles innovation by equating devices with pharmaceuticals.
Molbio Diagnostics Eyes ₹940 Crore from IPO, Targets High-Risk Investors
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
Medical Device Industry Challenges Draft Bill on Regulatory Grounds
India's medical device industry rejects draft bill equating devices to drugs, citing risks to innovation and investment.